EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medlive Technology Co's enterprise value is HK$1,349.6 Mil.
Medlive Technology Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$287.5 Mil. Therefore, Medlive Technology Co's EV-to-EBITDA for today is 4.69.
The historical rank and industry rank for Medlive Technology Co's EV-to-EBITDA or its related term are showing as below:
HKSE:02192'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.16 Med: 12.04 Max: 235.89
Current: 4.69
During the past 6 years, the highest EV-to-EBITDA of Medlive Technology Co was 235.89. The lowest was -7.16. And the median was 12.04.
HKSE:02192's EV-to-EBITDA is ranked better than 78.75% of 80
companies
in the Medical Distribution industry
Industry Median: 10.2
vs HKSE:02192: 4.69
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Medlive Technology Co EV-to-EBITDA Historical Data
The historical data trend for Medlive Technology Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medlive Technology Co's EV-to-EBITDA
For the Medical Distribution subindustry, Medlive Technology Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medlive Technology Co's EV-to-EBITDA Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medlive Technology Co's EV-to-EBITDA falls into.
Medlive Technology Co's current Enterprise Value is HK$1,349.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medlive Technology Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$287.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medlive Technology Co (HKSE:02192) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Medlive Technology Co's PE Ratio for today is calculated as:
Medlive Technology Co's share price for today is HK$8.37.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medlive Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.360.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Medlive Technology Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Medlive Technology Co (HKSE:02192) Business Description
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02192 has been successfully added to your 